FERHANOĞLU, A. B. Et Al. 2019. Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Long-Term Results of Multi-Center Experience in Turkey.. The 24th Congress of European Hematology Association , (Amsterdam, Netherlands).

FERHANOĞLU, A. B., ÖZBALAK, M. M., BEKÖZ, H. S., KARADURMUŞ, N., PAYDAŞ, S., TÜRKER, F. A., ... TUĞLULAR, A. T.(2019). Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Long-Term Results of Multi-Center Experience in Turkey. . The 24th Congress of European Hematology Association, Amsterdam, Netherlands

FERHANOĞLU, AHMET Et Al. "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Long-Term Results of Multi-Center Experience in Turkey.," The 24th Congress of European Hematology Association, Amsterdam, Netherlands, 2019

FERHANOĞLU, AHMET B. Et Al. "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Long-Term Results of Multi-Center Experience in Turkey.." The 24th Congress of European Hematology Association , Amsterdam, Netherlands, 2019

FERHANOĞLU, A. B. Et Al. (2019) . "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Long-Term Results of Multi-Center Experience in Turkey.." The 24th Congress of European Hematology Association , Amsterdam, Netherlands.

@conferencepaper{conferencepaper, author={AHMET BURHAN FERHANOĞLU Et Al. }, title={Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Long-Term Results of Multi-Center Experience in Turkey.}, congress name={The 24th Congress of European Hematology Association}, city={Amsterdam}, country={Netherlands}, year={2019}}